Melanoma cell growth is typically driven by the ERK/MAPK pathway, which is hyper‐activated in at least 80% of melanomas that occur through mutations in NRAS (~20%), BRAF (~50%) and NF1 (~14%) (Akbani et al., 2017). This evidence concerns the gene NRAS and melanoma.